StockTipsArenaBeta

BUY Biocon Ltd — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYBiocon Ltd

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))6 Jul 2026via NDTV Profit (Live)

Entry₹426.8Stated
Target₹485
Total upside +13.64% (call closed)
Stop loss₹399-6.51% risk
Exit₹3998 Jul 2026, 2:05 pm
Stop-loss hit-6.51%
Follow Sachin Janardan Sarvade for new calls(21% target hit, 52 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 121 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 10:41 am IST
2 supporting0 opposing
Supports the BUY call (2)

Biocon Ltd completed the acquisition of 1,15,36,956 equity shares of its material subsidiary, Biocon Biologics Limited (BBL), from 127 selling shareholders. In consideration, Biocon allotted 87,86,362

BSE · Company Update·29 Jun · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·19 Jun · 3w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.